🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objectives of this monocentric investigator initiated exploratory clini...
Status
Completed
Location
University Hospital Zurich, Division of Dermatology
Start Date
2012-07
Trial ID
NCT01628484
Treatments Being Tested
The EVE-PMS technology is intended for determination of intolerance or sens...
Status
Unknown
Location
Sheba Medical Center, Tel-Hashomer
Start Date
2009-04
Trial ID
NCT00866437
Treatments Being Tested
The dermatological testing of cosmetic products which are new on the market...
Status
Recruiting
Location
Inselspital Bern
Start Date
2017-02-10
Trial ID
NCT03024671
Treatments Being Tested
The EVE- technology is intended for determination of intolerance or sensiti...
Status
Unknown
Location
Depts. Gynecology and Obstetrics and 3rd Dept of Internal Medicine
Start Date
2010-06
Trial ID
NCT01175759
Treatments Being Tested
This is a proof of concept study to determine the safety and allergenicity ...
Status
Completed
Location
Center for Environmental Medicine, Asthma and Lung Biology
Start Date
2011-12
Trial ID
NCT01489514
Treatments Being Tested
The EVE-PMS technology is intended for determination of intolerance or sens...
Status
Unknown
Location
Tel Aviv Sourasky Medical Center
Start Date
2009-04
Trial ID
NCT00873262
Treatments Being Tested
The purpose of this study is to see if the recruitment of a certain cell ty...
Status
Completed
Location
Nationwide Children's Hospital
Start Date
2017-09-06
Trial ID
NCT03039101
The investigators hypothesize gold is inert and thereby there is no pure-go...
Status
Unknown
Location
Multiple Locations
Start Date
2024-06-01
Trial ID
NCT05284253
Treatments Being Tested
The study aims to assess the biological potency of the In-House Reference P...
Status
Completed
Location
Arkansas Children's Hospital
Start Date
2017-11-24
Trial ID
NCT03352726
Treatments Being Tested
Use of olopatadine ophthalmic solution (eye drops) will decrease allergy sk...
Status
Completed
Location
Vanderbilt Asthma, Sinus and Allergy Program Research
Start Date
2008-01
Trial ID
NCT00775658
Treatments Being Tested